Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Paolini John F., holds the title of CHIEF MEDICAL OFFICER at Kiniksa Pharmaceuticals International, plc.
On 2026-10-30, the insider transacted 192,000 shares.The shares were transacted at a weighted average price of $58.56 per share, resulting in a total market-relevant value of $11.2M.
Paolini John F. (CHIEF MEDICAL OFFICER) sold $11.2M of $KNSA
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.